We are live on ! Find out more
AHCO icon

AdaptHealth
AHCO

23 hedge funds and large institutions have $105M invested in AdaptHealth in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

5% more funds holding

Funds holding: 22 → 23 (+1)

4% less capital invested

Capital invested by funds: $110M → $105M (-$4.48M)

1.24% less ownership

Funds ownership: 36.28% → 35.04% (-1.2%)

Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
1
Calls
$2.46M
Puts
–
Net Calls
+$2.46M
Net Calls Change
+$2.09M

Top Buyers

Rank Fund Capital Flow
1
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$4.9M
2
PC
Periscope Capital
Ontario, Canada
+$493K
3
CI
Cowen Inc
New York
+$488K
4
Walleye Trading
Walleye Trading
New York
+$127K
5
HIM
HGC Investment Management
Ontario, Canada
+$9.79K

Top Sellers

Rank Fund Capital Flow
1
BCM
Basso Capital Management
Connecticut
-$8.19M
2
AA
AQR Arbitrage
Connecticut
-$1.47M
3
Morgan Stanley
Morgan Stanley
New York
-$7.84K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$19.6M – – –
LA
2
Linden Advisors
New York
$12.1M – – –
MCM
3
Moore Capital Management
New York
$9.81M – – –
TD Asset Management
4
TD Asset Management
Ontario, Canada
$7.39M – – –
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$7.37M – – –
AIMCA
6
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$7.36M – – –
AA
7
AQR Arbitrage
Connecticut
$7.21M -$1.47M -149,999 -17%
AGC
8
Angelo Gordon & Co
New York
$5.9M – – –
PC
9
Periscope Capital
Ontario, Canada
$5.53M +$493K +50,300 +10%
Tudor Investment Corp
10
Tudor Investment Corp
Connecticut
$4.92M +$4.9M +500,004 New
FTCM
11
Fir Tree Capital Management
New York
$4.91M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.32M – – –
HIM
13
HGC Investment Management
Ontario, Canada
$3.73M +$9.79K +1,000 +0.3%
Walleye Trading
14
Walleye Trading
New York
$1.11M +$127K +12,986 +13%
CFIC
15
City Financial Investment Company
United Kingdom
$981K – – –
DAM
16
Deltec Asset Management
New York
$980K +$20 +2 +0%
CI
17
Cowen Inc
New York
$969K +$488K +49,855 +102%
KPF
18
K2 Principal Fund
Ontario, Canada
$343K – – –
Marshall Wace
19
Marshall Wace
United Kingdom
$250K – – –
WAM
20
Weiss Asset Management
Massachusetts
$246K – – –
GCL
21
Glazer Capital LLC
New York
$10K – – –
UBS Group
22
UBS Group
Switzerland
$5K +$4.9K +500 New
Morgan Stanley
23
Morgan Stanley
New York
$2K -$7.84K -800 -80%
BCM
24
Basso Capital Management
Connecticut
– -$8.19M -852,607 Closed

AHCO Hedge Fund Activity: Q4 2018 in Review

23 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q4 2018, worth a combined $105M — down 4.1% from $110M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new AHCO positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Tudor Investment Corp, opening a new position worth an estimated $4.9M. The largest seller was Basso Capital Management, exiting entirely with an estimated $8.19M sold.

  • 23 institutional investors held AdaptHealth (AHCO) as of Q4 2018, up from 22 in Q3 2018.
  • Funds reported $105M of AdaptHealth stock for Q4 2018, down 4.1% quarter-over-quarter.
  • 2 funds opened new AdaptHealth positions in Q4 2018 and 1 closed out, a net change of +1 holder.
  • The largest AdaptHealth buyer in Q4 2018 was Tudor Investment Corp, an estimated $4.9M added.
  • The largest AdaptHealth seller in Q4 2018 was Basso Capital Management, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2018.